Skip to content

uniQure QURE Return on assets

Return on assets at other companies

Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
-46.7%+6.0pp
Denali Therapeutics Inc. logo
Denali Therapeutics Inc.DNLI
-40%+13.9pp
PTC Therapeutics logo
PTC TherapeuticsPTCT
33.5%+22.9pp
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
-23.2%+14.7pp
Krystal Biotech, Inc. logo
Krystal Biotech, Inc.KRYS
18.2%+5.4pp
BridgeBio Pharma logo
BridgeBio PharmaBBIO
-64.8%-9.5pp

Other financials

Income statement

See full
Revenue$3.6M+127%
Gross profit$3.3M+144%
Operating income-$45.7M-16.2%
Net income-$53.5M-22.7%
EPS (diluted)-$0.85-3.7%

Balance sheet

See full
Cash & equivalents$140.0M-35.6%
Total debt$63.3M-4.3%
Total equity$149.3M+343%
Total assets$778.7M+28.6%

Cash flow

See full
Operating cash flow-$38.2M+13.3%
CapEx$140.0K+11.1%
Free cash flow-$38.4M+13.2%

Valuation

See full
Market cap$3.09B+78.4%
Enterprise value$3.02B+124%
P/S170.9×+85.1×

Profitability

See full
Gross margin90.6%-2.9pp
Operating margin-1,059.7%+380pp
Net margin-1,154.4%+89.3pp
FCF margin-953.7%+169pp

Returns & leverage

See full
Return on equity-228.2%-11.6pp
Debt / equity0.4×-1.5×
Current ratio10.4×-1.6×

Where this comes from

Calculated from uniQure’s reported figures.

Based on trailing twelve months.

The official record: uniQure’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about uniQure's return on assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is uniQure's return on assets?
uniQure (QURE) reported return on assets of -30.2% in Q1 2026.
How has uniQure's return on assets changed year-over-year?
uniQure's return on assets increased by 4.6% year-over-year, from -31.6% to -30.2%.
What is the long-term trend for uniQure's return on assets?
Over 5 years (2020 to 2025), uniQure's return on assets has grown at a -1.9% compound annual growth rate (CAGR), from -31.7% to -28.8%.
What does return on assets mean?
Trailing-twelve-month net income divided by average total assets. Measures how efficiently the asset base generates profit, independent of how those assets are financed. Computed as net income over average total assets — note this is OpenCapital's standard definition and may differ from data vendors that use alternative numerators.